MULTIDRUG RESISTANCE PROTEINS OF THE ABCC SUBFAMILY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 312

238. Eid H, Mingfang L, Institoris E, Bodrogi I, Bak M. 2000. MRP expression of testicular
cancers and its clinical relevance. Anticancer Res 20:4019-4022.
239. Ruggeri RM, Sciacchitano S, Vitarelli E, Trimarchi F, Barresi G, Trovato M. 2006. Im-
munoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary
thyroid carcinomas. Arch Pathol Lab Med 130:1014-1019.
240. Oshika Y, Nakamura M, Tokunaga T, Fukushima Y, Abe Y, Ozeki Y, Yamazaki H, Tamaoki
N, Ueyama Y. 1998. Multidrug resistance-associated protein and mutant p53 protein
expression in non-small cell lung cancer. Mod Pathol 11:1059-1063.
241. Berger W, Setinek U, Hollaus P, Zidek T, Steiner E, Elbling L, Cantonati H, Attems
J, Gsur A, Micksche M. 2005. Multidrug resistance markers P-glycoprotein, multidrug
resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic
implications. J Cancer Res Clin Oncol 131:355-363.
242. Nooter K, Brutel DLR, Look MP, van Wingerden KE, Henzen-Logmans SC, Scheper
RJ, Flens MJ, Klijn JG, Stoter G, Foekens JA. 1997. The prognostic significance of
expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.
Br J Cancer 76:486-493.
243. Rudas M, Filipits M, Taucher S, Stranzl T, Steger GG, Jakesz R, Pirker R, Pohl G. 2003.
Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative
chemotherapy. Breast Cancer Res Treat 81:149-157.
244. Sullivan GF, Amenta PS, Villanueva JD, Alvarez CJ, Yang JM, Hait WN. 1998. The
expression of drug resistance gene products during the progression of human prostate
cancer. Clin Cancer Res 4:1393-1403.
245. Poulain S, Lepelley P, Preudhomme C, Cambier N, Cornillon J, Wattel E, Cosson A,
Fenaux P. 2000. Expression of the multidrug resistance-associated protein in myelodys-
plastic syndromes. Br J Haematol 110:591-598.
246. Filipits M, Stranzl T, Pohl G, Suchomel RW, Zochbauer S, Brunner R, Lechner K, Pirker
R. 1999. MRP expression in acute myeloid leukemia: an update. Adv Exp Med Biol
457:141-150.
247. Sasaki M, Suzuki H, Ito K, Abe T, Sugiyama Y. 2002. Transcellular transport of or-
ganic anions across a double-transfected Madin-Darby canine kidney II cell monolayer
expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and
multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem 277:6497-6503.
248. Keppler D. 2005. Uptake and efflux transporters for conjugates in human hepatocytes.
Methods Enzymol 400:531-542.
249. Walgren RA, Karnaky KJ Jr, Lindenmayer GE, Walle T. 2000. Efflux of dietary flavonoid
quercetin 4 -beta-glucoside across human intestinal Caco-2 cell monolayers by apical
multidrug resistance-associated protein-2. J Pharmacol Exp Ther 294:830-836.
250. Horio M, Pastan I, Gottesman MM, Handler JS. 1990. Transepithelial transport of vin-
blastine by kidney-derived cell lines. Application of a new kinetic model to estimate in
situ K m of the pump. Biochim Biophys Acta 1027:116-122.
251. Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki
M, Naitoh T, Matsuno S, Yawo H. 1999. Identification of a novel gene family encoding
human liver-specific organic anion transporter LST-1. J Biol Chem 274:17159-17163.
252. Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG. 1999. A
novel human hepatic organic anion transporting polypeptide (OATP2). Identification of
a liver-specific human organic anion transporting polypeptide and identification of rat